Exicure, Inc. Common Stock

XCURNASDAQUSD
1.37 USD
0.03 (2.14%)AT CLOSE (11:59 AM EDT)
1.35
0.02 (1.46%)
POST MARKET (AS OF 06:19 PM EDT)
Post Market
AS OF 06:19 PM EDT
1.35
0.02 (1.46%)
🔴Market: CLOSED

Exicure, Inc. Common Stock (XCUR) is currently trading at $1.37. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, XCUR trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Sep 14, 2026.

Open?$1.35
High?$1.40
Low?$1.33
Prev. Close?$1.40
Volume?14.0K
Avg. Volume?46.4K
VWAP?$1.35
Rel. Volume?0.30x
Bid / Ask
Bid?$1.00 × 100
Ask?$1.64 × 100
Spread?$0.64
Midpoint?$1.32
Valuation & Ratios
Market Cap?9.2M
Shares Out?6.5M
Float?4.3M
Float %?67.2%
P/E Ratio?N/A
P/B Ratio?9.38
EPS?-$1.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
Employees
8
Market Cap
9.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-05-09
Address
2430 N. HALSTED ST.
CHICAGO, IL 60614
Phone: 847-673-1707
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
100
Piotroski F-Score?0/9Weak
Altman Z-Score?-25.50Distress
Confidence?43%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.19%Low
Short Interest?50.8K
Days to Cover?1.1
Free Float4.3M
Avg Daily Volume46.9K
Settlement Date2026-08-31
Financial Health
Current Ratio?0.56Weak
Quick Ratio?0.56Weak
Cash Ratio?0.41Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
20
9.38HIGH
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-1.1CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-847.9%WEAK
ROA?
S&P
3
-72.7%WEAK
Cash Flow & Enterprise
FCF?$-7023000
Enterprise Value?$7.4M
Fundamentals ratios updated end of day